Dr. Nisrine Bou Malhab, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd Bldg A, Pikeville, KY 41501 Phone: 606-430-2208 Fax: 606-218-7508 |
Shadi Falah Obeidat, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd, 8th Floor Clinic Building, Pikeville, KY 41501 Phone: 606-218-3500 |
News Archive
LifeWatch Services, Inc., a subsidiary of LifeWatch AG, will unveil its advanced AF TeleClinic service offering this week at the Heart Rhythm Society (HRS) Annual Meeting taking place in Denver, Colorado. The AF TeleClinic service, empowered with the latest communication, IT and medical technologies, ensures physicians are well equipped to deliver optimal diagnostic and treatment options to their patients.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has signed an asset purchase agreement with Nephromics LLC, which includes a patent license for exclusive rights to use PlGF for the diagnosis of pre-eclampsia or eclampsia. Clinical trials have shown that PlGF supports the diagnosis and risk prediction for preeclampsia.
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation detection platform - the nCounter Human Karyotype Panel.
Inflammatory bowel disease (IBD) is an umbrella term that describes many disorders that involve chronic inflammation of the digestive tract, including ulcerative colitis and Crohn's disease. These conditions are tied to certain alternations in the gut flora.
Rowan T. Chlebowski, M.D., Ph.D., an LA BioMed investigator whose research activities have focused on breast cancer therapy and prevention, and chronic diseases impacting women's health, is co-author of a study that indicates that women who use the estrogen-only form of menopausal hormone therapy appear less likely to develop breast cancer in the longer term, according to new research which was recently published The Lancet Oncology.
› Verified 4 days ago